ANNALS OF PHARMACOTHERAPY

ANNALS OF PHARMACOTHERAPY

ANN PHARMACOTHER
影响因子:2.3
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:SAGE Publications Inc.
发刊时间:1992
发刊频率:Monthly
收录数据库:SCIE/Scopus收录
ISSN:1060-0280

期刊介绍

Annals of Pharmacotherapy (AOP) is a peer-reviewed journal that advances pharmacotherapy throughout the world by publishing high-quality research and review articles to achieve the most desired health outcomes.The articles provide cutting-edge information about the most efficient, safe and cost-effective pharmacotherapy for the treatment and prevention of various illnesses. This journal is a member of the Committee on Publication Ethics (COPE). Average time from submission to first decision: 14 days
《药物治疗年鉴》(AOP)是一份同行评审期刊,通过发表高质量的研究和评论文章来推动全世界的药物治疗,以实现最理想的健康结果。文章提供了关于治疗和预防各种疾病的最有效、安全和成本效益最高的药物治疗的前沿信息。该杂志是出版伦理委员会(科普)的成员。从提交到首次作出决定的平均时间:十四天
年发文量 92
国人发稿量 5.54
国人发文占比 0.06%
自引率 -
平均录取率0
平均审稿周期 一般,3-8周
版面费 US$4000
偏重研究方向 医学-药学
期刊官网 http://aop.sagepub.com/
投稿链接 https://us.sagepub.com/en-us/nam/annals-of-pharmacotherapy/journal202238#submission-guidelines

期刊高被引文献

Baricitinib: The Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019839650
Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018796604
Need for a Judicious Use of Nonsteroidal Anti-inflammatory Drugs to Avoid Community-Acquired Acute Kidney Injury
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018789174
Medication Regimen Complexity and Hospital Readmission in Older Adults With Chronic Kidney Disease
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018793419
Brigatinib: Novel ALK Inhibitor for Non–Small-Cell Lung Cancer
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018824578
Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019865224
Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019873320
Erenumab: A First-in-Class Monoclonal Antibody for Migraine Prevention
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019835166
Review of Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Advanced Breast Cancer
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018793656
Evaluation of Intravenous Phenytoin and Fosphenytoin Loading Doses: Influence of Obesity and Sex
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018818785
Emergency Department Visits for Psychotropic-Related Adverse Drug Events in Older Adults With Alzheimer Disease, 2013-2014
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019866927
Adverse Drug Events as a Reason for Adult Hospitalization: A Nationwide Readmission Study
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018818571
Cardiovascular Risk Reduction in the Workplace With CAMMPUS (Cardiovascular Assessment and Medication Management by Pharmacists at the UBC Site)
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018823330
Dalbavancin Use in the Emergency Department Setting
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019855159
Reply: Managing Diabetes and Preventing Heart Disease: Have We Found a Safe and Effective Agent?
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019862262
Sufentanil Sublingual Tablet: A New Option for Acute Pain Management
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019863144
Clinical Outcomes Associated With Once-Daily Ritonavir-Boosted Darunavir Plus Tenofovir/Emtricitabine in HIV-Infected Patients Harboring at Minimum a M184V/I Resistance Mutation
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018790574
Incidence of Acute Kidney Injury in Intermittent Versus Continuous Infusion of Polymyxin B in Hospitalized Patients
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019841898
Intravenous Olanzapine for the Management of Agitation: Review of the Literature
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019831634
Understanding and Preventing (N-Nitrosodimethylamine) NDMA Contamination of Medications
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019892222
Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target–Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019897100
Evaluation of Treatment-Dose Enoxaparin in Acutely Ill Morbidly Obese Patients at an Academic Medical Center: A Randomized Clinical Trial
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018821149
Nondihydropyridine Calcium Channel Blockers for the Treatment of Proteinuria: A Review of the Literature
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019843644
A Comparison of Resource Utilization in the Management of Anticholinergic Delirium Between Physostigmine and Nonantidote Therapy
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019846654
Systemic Corticosteroid and Antibiotic Use in Hospitalized Patients With Chronic Obstructive Pulmonary Disease Exacerbation
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018799696
Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019871891
Hepatitis C Treatment Differences in Elderly Patients: Single-Center Retrospective Study
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019871352
β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019862322
Management of Tumor Necrosis Factor α Inhibitor Therapy After Renal Transplantation: A Comparative Analysis and Associated Outcomes
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018802814
Effectiveness of Methenamine for UTI Prevention in Older Adults
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019886308
Association Between Cognitive Tests and Antiretroviral Medication Adherence in Older Adults With HIV
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018798327
Effectiveness, Safety, and Economic Comparison of Inhaled Epoprostenol Brands, Flolan and Veletri, in Acute Respiratory Distress Syndrome
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019888853
Intrapleural Tissue Plasminogen Activator for Traumatic Retained Hemothorax
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019846122
Development of a Drug Information Service Collaborative in Academia
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019884079
Utilization of Intra-airway Injection of Iopamidol
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019843652
Effect of an Asthma Question Prompt List and Video Intervention on Adolescents’ Medication Adherence 12 Months Later
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019831259
Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019897267
Engineering a Brighter Future: The Evolving Role of the Pharmacist in the Era of the HeartMate 3
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018813371
Race-Specific Patterns of Treatment Intensification Among Hypertensive Patients Using Home Blood Pressure Monitoring: Analysis Using Defined Daily Doses in the Heart Healthy Lenoir Study
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018806001
Common Questions and Misconceptions in the Management of Renal Transplant Patients: A Guide for Health Care Providers in the Posttransplant Setting
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018809318
Opioid and Benzodiazepine Requirements in Obese Adult Patients Receiving Extracorporeal Membrane Oxygenation
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019872940
Adjunct Antihyperglycemic Agents in Overweight and Obese Adults With Type 1 Diabetes
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018816728
Unintended Impact of US Food and Drug Administration Recalls on the Use of Contaminated and Non-Contaminated Angiotensin Receptor Blockers Among Medicaid Beneficiaries
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019897388
Comment: Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028018798755
A Previously Unknown Drug-Drug Interaction Is Suspected in Delayed Elimination of Plasma Methotrexate in High-Dose Methotrexate Therapy
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019870445
Intravesicular Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019897896
Liver Injury After Occasional Energy Drink Use in a Patient Living With HIV and Diabetes
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019883811
Patient Satisfaction With Extended International Normalized Ratio Follow-up Intervals in a Veteran Population
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019889414
Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019882035
Glecaprevir/Pibrentasvir: The First 8-Week, Pangenotypic HCV Treatment Regimen for Patients 12 Years of Age and Older
来源期刊:Annals of PharmacotherapyDOI:10.1177/1060028019877128

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
61.96%2.2%-0.82%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q3区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
PHARMACOLOGY & PHARMACY
Q3

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
2023年12月升级版
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
2022年12月旧的升级版
医学3区
PHARMACOLOGY & PHARMACY 药学
3区